Mark Sullivan, MD, PhD

Personal Statement

My clinical service and research focuses on the interaction of mental and physical illness, especially in patients with chronic pain. Much of my research in recent decades has focused on the risks of treating chronic pain with opioids. I have developed educational programs and outcome tracking tools to assist with opioid treatment of chronic pain. I have published a book about patient empowerment in chronic disease care, The Patient as Agent of Health and Health Care (Oxford, 2017). I have another book written with Jane Ballantyne forthcoming, The Right to Pain Relief and other deep roots of the opioid epidemic (Oxford, 2022).

Education

Vanderbilt Univ. Sch. of Medicine Medical education, 1984
Univ. of Missouri Columbia Internship, Family Medicine
UW - Dept. of Psychiatry & Behavioral Sciences Residency, Psychiatry

Department Affiliations

Other Affiliations

UWMC Center for Pain Relief

Teaching Philosophy

‚ÄčI like to have trainees manage patients under my supervision. Trainees need real responsibility to learn and develop management skills.
In didactic sessions, I strive for interaction between myself and trainees. I generally teach in a seminar format centered around case presentations. I expect all trainees to contribute to the discussion and the learning of others.

Recent Publications

Characteristics of patients with non-cancer pain and long-term prescription opioid use who have used medical versus recreational marijuana.
(2024 Feb 22)
J Cannabis Res 6(1): 7
Davidson WM, Mahavni A, Chrusciel T, Salas J, Miller-Matero LR, Sullivan MD, Zabel C, Lustman PJ, Ahmedani BK, Scherrer JF

A facility-level self-assessment of Autonomous Pharmacy Framework levels.
(2024 Apr 19)
Am J Health Syst Pharm 81(9): e240-e248
Goldsmith N, Sullivan M, Cole SW, Mathen G, Polis N, Sisodiya D, Tanner T, Wagner J, Flynn AJ

Design of a Multicenter Randomized Controlled Trial comparing the effectiveness of shared decision making versus motivational interviewing plus cognitive behavioral therapy for voluntary opioid tapering: The INSPIRE study protocol.
(2024 Feb)
Contemp Clin Trials 137(): 107410
Edlund MJ, Thomas SM, Wagner LK, Thompson JE, Wu LT, Dolor RJ, Chelminski PR, Ives TJ, Archer KR, Dewey CM, Sullivan MD, McCormack LA, INSPIRE Study Team

Utilisation of molecularly imprinting technology for the detection of glucocorticoids for a point of care surface plasmon resonance (SPR) device.
(2024 Jan 2)
Anal Chim Acta 1285(): 342004
Blackburn C, Sullivan MV, Wild MI, O' Connor AJ, Turner NW

Baseline Characteristics From a New Longitudinal Cohort of Patients With Noncancer Pain and Chronic Opioid Use in the United States.
(2024 Apr)
J Pain 25(4): 984-999
Secrest S, Miller-Matero LR, Chrusciel T, Salas J, Sullivan MD, Zabel C, Lustman P, Ahmedani B, Carpenter RW, Scherrer JF

Show complete publication list »
Edit Profile